Table 1 Comparison of currently available CGM systems.
From: Expanding the horizon of continuous glucose monitoring into the future of pediatric medicine
Dexcom G6 | Dexcom G7 | Libre 2+ | Libre 3 | Eversense E3 | Medtronic Guardian 4 | |
|---|---|---|---|---|---|---|
Accuracy (MARD) | Pediatrics: 7.7–10.1% | Ages 7–17 yrs: 8.1–9.0% Ages 2–6 yrs: 9.3% | Pediatrics: 9.7% Adult: 9.2% | Overall: 7.9% | Overall 8.5% | Pediatrics: 7–17 yrs: 11.6% Adults: 10.6% |
FDA approval | Ages 2 years and up | Ages 2 years and up | Ages 2 years and up | Ages 4 years and up | Adults only | Ages 7 years and up |
Follow or Sharing Data option | Yes, Dexcom Follow | Yes, Dexcom Follow | No, when used with AID system, data only available from the AID system | Yes, LibreView | Yes, Eversense NOW | Yes, Guardian Connect |
Insertion Device | Auto-applicator, one touch sensor insertion, transmitter is a separate device to be clipped to sensor | Sensor and transmitter insert together, disposable transmitter | Sensor and transmitter insert together, disposable transmitter | Sensor and transmitter insert together, disposable transmitter | Minor office procedure to insert sensor | Auto-applicator, transmitter is a separate device to be clipped to sensor |
Interferences | -Hydroxyurea -Has acetaminophen blocker | -Hydroxyurea -Has acetaminophen blocker | -High dose Vit. C | -High dose Vit C | -No acetaminophen interference | -Hydroxyurea |
Wear time | 10 days | 10 days | 15 days | 14 days | 180 days | 7 days |
Warm up time | 120 min | 30 min | 60 min | 60 min | 24 h | 120 min |
Interoperability with Currently Available AID Systems | -CamAPS FX -Control IQ -Omnipod 5 -iLet Bionic Pancreas | -Control IQ -Omnipod 5 -iLet Bionic Pancreas | -Control IQ -Omnipod 5 (Europe only at time of publication) | -CamAPS FX | None | Medtronic 780 G |
